Nantahala Capital Management, LLC Exagen Inc. Transaction History

Nantahala Capital Management, LLC

$1.55 Billion
Q1 2024

A detailed history of Nantahala Capital Management, LLC transactions in Exagen Inc. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 74,306 shares of XGN stock, worth $135,236. This represents 0.01% of its overall portfolio holdings.

Number of Shares

74,306

Previous 97,124 23.49%

Holding current value

$135,236

Previous $193,000 38.86%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.42 - $2.3 $32,401 - $52,481	-22,818 Reduced 23.49%	74,306 $118,000
Q4 2023 Feb 14, 2024	SELL	$1.45 - $2.39 $13,985 - $23,051	-9,645 Reduced 9.03%	97,124 $193,000
Q3 2023 Nov 14, 2023	SELL	$2.24 - $2.93 $33,880 - $44,316	-15,125 Reduced 12.41%	106,769 $258,000
Q2 2023 Aug 14, 2023	SELL	$2.36 - $3.48 $25,296 - $37,302	-10,719 Reduced 8.08%	121,894 $353,000
Q1 2023 May 15, 2023	SELL	$2.23 - $2.9 $31,099 - $40,443	-13,946 Reduced 9.52%	132,613 $322,000

Q4 2022 Feb 14, 2023	SELL	$2.1 - $3.4 $8,349 - $13,518	-3,976 Reduced 2.64%	146,559 $351,000
Q3 2022 Nov 10, 2022	SELL	$3.43 - $8.68 $19,208 - $48,608	-5,600 Reduced 3.59%	150,535 $408,000
Q2 2022 Aug 15, 2022	SELL	$4.18 - $7.74 $13,033 - $24,133	-3,118 Reduced 1.96%	156,135 $896,000
Q1 2022 May 13, 2022	SELL	$7.12 - $11.06 $197,102 - $306,173	-27,683 Reduced 14.81%	159,253 $1.28 Million
Q4 2021 Feb 14, 2022	SELL	$8.97 - $14.08 $221,379 - $347,494	-24,680 Reduced 11.66%	186,936 $2.17 Million
Q3 2021 Nov 15, 2021	SELL	$10.25 - $15.21 $1.6 Million - $2.38 Million	-156,320 Reduced 42.49%	211,616 $2.88 Million
Q2 2021 Aug 16, 2021	SELL	$12.4 - $17.92 $79,099 - $114,311	-6,379 Reduced 1.7%	367,936 $5.52 Million
Q1 2021 May 14, 2021	BUY	$13.9 - $22.0 $5.2 Million - $8.23 Million	374,315 New	374,315 $6.55 Million

Others Institutions Holding XGN

# of Institutions

Shares Held

6.21M

Call Options Held

1.6K

Put Options Held

4.1K

View Full List

About EXAGEN INC.

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $29.6M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

More about XGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Account

Nantahala Capital Management, LLC Exagen Inc. Transaction History